Region: Europe

UPC looks set for first antitrust spat in unusual life sciences dispute

The plot continues to thicken in 10x Genomics’ multi-faceted spat with NanoString

13 July 2023

The EUIPO must understand what taking on SEPs will mean

Any notion that the plans set out in DG GROW’s controversial regulation can be quietly implemented for an audience of largely supportive stakeholders will not survive contact with reality

13 July 2023

Ericsson’s patent strategy is evolving, says VP of global licensing

Exclusive interview with Roy Maharaj on new opportunities for patent monetisation and IP licensing tips

11 July 2023

Apple voting rights expansion triggers 3GPP rule change

To avoid ‘arms race’ among members, world’s most important group of Standards Development Organisations set to introduce new restrictions

10 July 2023

Moderna files Irish lawsuit against Pfizer/BioNTech in ever-expanding covid dispute

Complex web of mRNA patent litigation has now spread to Ireland

07 July 2023

The EUIPO’s role will be as a facilitator, not an SEP deal maker

Outgoing executive director Christian Archambeau says office will work as an administrative entity only if European Commission plans to regulate SEP licensing come into force

06 July 2023

IP rocks – shout it to the world!

There is no excuse for not embracing diversity, equity and inclusion as part of the effort to attract and retain talent, but solving IP’s visibility problem is what will deliver the most meaningful results

06 July 2023

Huawei files UPC suit to ramp up pressure in Netgear SEP dispute

Chinese patentee is seeking to boost patent revenues from Wi-Fi 6 portfolio and other new segments

05 July 2023

UPC already a hit with patentees in Germany

The majority of filings so far have been in Germany, establishing Munich as a key destination. The number of international disputes is also expected to surge as English is introduced as a language option for proceedings.

05 July 2023

How life sciences companies are embracing the UPC

Pharma, biotech and medical device companies have surprised the patent community with their dominance of early proceedings at the new court

04 July 2023

Unlock unlimited access to all IAM content